Phagocytosis of SARS-CoV-2 nucleocapsid- and RNA-containing immune complexes drives inflammatory cytokine production and endothelial dysfunction
Authors:
Open Access
- 29 October 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (10) , e1014664
Abstract
The aberrant inflammation that characterizes severe COVID-19 is incompletely understood. Given the persistence of SARS-Cov-2 RNA and nucleocapsid protein (N) and the presence of anti-N antibody during the course of severe infection, we investigated the role of RNA-containing immune complexes (ICs) in driving inflammation. We found that ICs consisting of SARS-CoV-2 RNA, N, and anti-N IgG1 are internalized by primary human monocytes and stimulate inflammatory cytokines and chemokines in a manner dependent on Fcγ receptors and partially dependent on Toll-Like Receptor-(TLR)8. In addition, the inflammatory response induced in monocytes by RNA-containing ICs caused endothelial dysfunction in vascularized micro-organs. Using nasopharyngeal samples from SARS-CoV-2-infected individuals, SARS-CoV-2 RNA and N were captured by anti-N monoclonal antibody in the absence of lysing agents, indicating that SARS-CoV-2 RNA and N complexes are present outside of virions and cells. Finally, we found that during an early wave of COVID-19, higher anti-N IgG:IgM ratios were associated with more severe clinical outcomes, consistent with a role for inflammatory, IgG-mediated phagocytic clearance of nucleic acid-containing ICs in SARS-CoV-2 pathogenesis, perhaps mitigated by non-inflammatory, IgM-mediated clearance. We conclude that RNA-containing ICs may play a role in the pathogenesis of severe COVID-19. Since all pathogenic viruses encode nucleic acid-binding proteins such as N, and these proteins often elicit an antibody response, inflammatory clearance of nucleic acid-containing ICs may also contribute to disease severity in other viral infections.Keywords
Funding Information
- University of California
- National Center for Advancing Translational Sciences (UM1TR004927)
- National Cancer Institute (P30CA062203)
This publication has 70 references indexed in Scilit:
- Persistent Interleukin‐1β Elevation in Post‐COVID‐19 Patients: Findings From a Nationwide Registry Study in JapanNeuropsychopharmacology Reports, 2026
- Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisJournal of Neurology, 2024
- Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceInfection, 2024
- SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosisClinical Rheumatology, 2023
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Bleach gel: A simple agarose gel for analyzing RNA qualityElectrophoresis, 2012
- Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronavirusesProteomics, 2005
- Measles virus protein‐specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infectionJournal of Medical Virology, 2003